Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01450540 · ClinicalTrials.gov registry record · NA
Automated Graduated CPAP (AGPAP) for Improved Adherence in Newly Diagnosed Obstructive Sleep Apnea (OSA) Patients
A NA study, sponsored by Philips Respironics.
- Completed
- Registry status
- NA
- Development phase
- 241
- Enrollment target
NCT01450540 is a NA study that has completed, run by Philips Respironics. The registered enrollment target is 241 participants.
The verdict
NCT01450540, a NA study, has completed, sponsored by Philips Respironics.
- COMPLETED
- Registry status
- NA
- Development phase
- 241 participants
- Enrollment target
Study Summary
Although positive airway pressure (PAP) is a highly effective treatment for sleep apnea, adherence to therapy remains an obstacle. Automated Graduated CPAP (AGPAP), also know as EZ-start, is an extended duration ramp, where the patient receives pressure below their prescription during an acclimation phase. The algorithm gradually increases pressure to therapy level based on usage. The aim of this study was to determine the effectiveness of the AGPAP acclimation period and its impact on short term adherence.
Interventions
- DEVICE REMstar Auto A-Flex
- DEVICE modified REMstar Auto A-Flex with AGPAP
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 241 participants |
| Start Date | 2011-09 |
| Est. Completion | 2013-04 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01450540
The ClinicalTrials.gov registry entry for NCT01450540 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 241 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Philips Respironics, which has 35 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which REMstar Auto A-Flex is the first listed.
NCT01450540 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01450540 about?
NCT01450540 is a clinical study titled "Automated Graduated CPAP (AGPAP) for Improved Adherence in Newly Diagnosed Obstructive Sleep Apnea (OSA) Patients". Although positive airway pressure (PAP) is a highly effective treatment for sleep apnea, adherence to therapy remains an obstacle. Automated Graduated CPAP (AGPAP), also know as EZ-start, is an extended duration ramp, where the patient receives pressure below their prescription during an acclimation...
What is the current status of trial NCT01450540?
This trial is currently completed. It is a NA study. The enrollment target is 241 participants. The study started on 2011-09. Estimated completion is 2013-04.
What interventions are being tested in trial NCT01450540?
The interventions under investigation include: REMstar Auto A-Flex (DEVICE), modified REMstar Auto A-Flex with AGPAP (DEVICE).
Who is sponsoring clinical trial NCT01450540?
This trial is sponsored by Philips Respironics, which has 35 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.